REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/01/2025
Back to search
Official data from USPTO
PRUGEN PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
06/02/2025
Trademark type
Combined
Nice classes
5
Filing date
07/21/2014
Registration date
05/31/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/19/2022
Last transaction
06/02/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
05/05/2011
First use in commerce
05/05/2011
Drawing code
3
Owner type
16
Owner location
Scottsdale, AZ
Examiner
ARANT, LUCY
Law office
M80
Current location
TMO LAW OFFICE 117
Mark description
The mark consists of a circle design consisting of four nested circles, the three inner circles all meeting on the lower edge of the three circles with the upper edge of the outermost inner circle meeting at the top edge of the outer circle, followed by the word "PruGen", all over a horizontal line, over the word "PHARMACEUTICALS".
Holders and representatives
Holders
PRUGEN, LLC
PruGen IP Holdings, Inc.
Representatives
Yakov Sidorin Quarles & Brady LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
41 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/19/2022
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/19/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/19/2022
E815
TEAS SECTION 8 & 15 RECEIVED
05/13/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/31/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/03/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/03/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/03/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/03/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/03/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/17/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/17/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/03/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
05/31/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/15/2016
PUBO
PUBLISHED FOR OPPOSITION
03/15/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/24/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/05/2016
ALIE
ASSIGNED TO LIE
01/27/2016
ALIE
ASSIGNED TO LIE
01/19/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/18/2015
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/03/2015
DPCC
DIVISIONAL PROCESSING COMPLETE
11/02/2015
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/02/2015
DRRR
DIVISIONAL REQUEST RECEIVED
10/30/2015
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/30/2015
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
10/30/2015
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/03/2015
GNFR
FINAL REFUSAL E-MAILED
05/03/2015
CNFR
FINAL REFUSAL WRITTEN
05/03/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/15/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/14/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/14/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/31/2014
GNRT
NON-FINAL ACTION E-MAILED
10/31/2014
CNRT
NON-FINAL ACTION WRITTEN
10/31/2014
DOCK
ASSIGNED TO EXAMINER
10/31/2014
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/29/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/28/2014
NWAP
NEW APPLICATION ENTERED
07/24/2014
Continuous trademark protection
Get notified about every new filing that threatens PRUGEN PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.